ARGENTINE FIRM LOOKS TO EXPAND

21 June 1992

Argentina is one of the Latin American countries that is fighting to turn around its economic and political fortunes. Since Carlos Menem became president of the country, and Domingo Cavallo took on the position of Minister for the Economy, Argentina's economy has experienced a dramatic turnaround, two main features being the move from hyperinflation to a level of 0.35% for the month of May, and the privatization of state industries.

In January of the current year, Decree 150 announced the deregulation of the pharmaceutical industry, from product registration to distribution of medicines.

Doctors have to prescribe products by their generic name, but they can be obtained from outlets other than pharmacies, such as supermarkets, if the product is approved. Registration for manufacture can be obtained within 40 days, and for the importing of medicines, approval is effective immediately.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight